WCN26-263 NanoHPLC-MS-Based Urinary Proteomic Signatures Predict Remission and Relapse in Primary Membranous Nephropathy

Read full text Summarise with VIRAT
Authors: Lu Zeng, Hui Peng
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Primary membranous nephropathy (PMN) is one of the leading causes of nephrotic syndrome in adults, yet its reliable prognostic assessment tools remain limited. Although traditional clinical indicators and serum anti-PLA2R antibody have been widely used, they still cannot fully reflect the individualized treatment response of PMN patients. Identifying multifactorial risk profiles facilitates more precise therapeutic guidance. This study aims to identify novel urine protein prognostic biomarkers in PMN patients and uncover relapse-associated molecular subtypes in PMN.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Systemic Lupus Erythematosus Research Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104412–104412
Publication date
25 March 2026
Language
EN